Schooner Capital
VC Fund
Boston, United States
Schooner Capital is a private investment office. The firm has no outside limited partners and approaches all investments with a long-term perspective.
- Total investments:
- 76
- Last investment:
- Lead investor:
- 50%
Last updated:
For AI agents: llms.txt
Industries Schooner Capital invests in
Stages Schooner Capital invests in
Countries Schooner Capital invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
| See all 10 contacts → | |||
Round size
- Series A
- $2.3M–$84M
- Venture - Series Unknown
- $1.5M–$21M
Investment Focus
Industry
- Software 12 (16%)
- Biotechnology 12 (16%)
- Health Care 10 (13%)
- Information Technology 7 (9%)
- Medical 6 (8%)
Stage
- Series A 13 (17%)
- Funding Round 12 (16%)
- Venture - Series Unknown 12 (16%)
- Seed 10 (13%)
- Series B 10 (13%)
Country
- United States 39 (51%)
- Ireland 2 (3%)
- India 1 (1%)
- Canada 1 (1%)
- Israel 1 (1%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Alexandra Manick
Principal
|
Principal | Total investments: 3 | Find email | |
Jake Fiechter
Analyst
|
Analyst | Total investments: 0 | Find email | |
|
Jon Corbett
Vice President of Finance
|
Vice President of Finance | Total investments: 0 | Find email | |
|
Lou Stathis
Accountant
|
Accountant | Total investments: 0 | Find email | |
|
Orhan Gazelle
Principal; Managing Director
|
Principal; Managing Director | Total investments: 8 | Find email | |
| See all 10 team members → | ||||
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| MarginEdge develops food and beverage tracking and analytics. | $80M / Series D / Aug 06, 2026 | ||
| Manna is a Drone Delivery “As a Service” business. We enable, transform and grow local businesses of all types by powering a 3-minute delivery service across a 30 square mile catchment area for them. Reaching more customers - more quickly and in a more scalable way than road-based delivery.Manna is regulated by the relevant aviation regulatorybodies in Europe and USA. | $50M / Series B / Apr 01, 2026 | ||
| KEWAZO is digitizing construction with robotics and data analytics. We integrate robotic platforms on-site to enable digital services. In scaffolding, our robotic material hoist LIFTBOT saves up to 44% of labor costs, addresses labor shortage, and improves safety. By having our robots on-site, we collect operational data and provide it to ourcustomers in the form of a data analytics platform, enabling more proactive management of both individual projects and companies overall. | $16M / Series A / Mar 19, 2026 | ||
| Carecubes develops medical-grade isolation technology that helps caregivers respond to pandemics in a calm and caring manner. | $6.5M / Series A / Mar 19, 2026 | ||
| Remedy Plan Therapeutics is a pre-clinical-stage company developing small molecule therapeutics to halt tumor growth and disrupt the cancer stem cells that cause metastasis. Our approach is to develop effective, non-toxic treatments that target the dangerous embryonic properties of cancer stem cells, which form the basis for cancer growth, spread,and resistance to chemotherapy. Remedy Plan is positioned to deliver one first-in-class drug candidate for Phase I clinical development approximately 15 months after Series A fundingRemedy Plan's proprietary drug screening platform identifies drug candidates that differentiate cancer stem cells, disrupt proliferation, and inhibit formation of new tumors. From the initial screen of 40,000 drug components, a lead candidate is currently undergoing optimization and mechanism of action studies in preparation for Phase I clinical trials. With the second screen of over 100,000 drug components completed, Remedy Plan aims to have at least two drugs in clinical development by 2020. | $18M / Venture - Series Unknown / May 13, 2025 | ||
| Onebeat helps retailers, wholesalers, and brands achieve results through operational optimization. It offers solutions for the needs of the technology of retail. It develops platforms that aim to help businesses optimize how they handle their retail. It's headquarters is in Petach Tikva in Israel and it has branches globally. | $15M / Series C / May 06, 2025 | ||
| Ottometric provides an intelligent verification framework that gives deeper understanding of events and anomalies, helping the industry deliver safer vehicles. The race to get reliable ADAS features to vehicles is speeding up, from driver assistance to full self driving. The industry is investing greatly to innovate. Today, the auto industry isdelivering Level 1 to Level 3 Autonomous capabilities that industry stakeholders have called out as sub-par. | $10.3M / Series A / Apr 09, 2025 | ||
| Meili is a built technology that allows mobility company to interact with travel partners offering a frictionless consumer experience. | $8.5M / Seed / Dec 12, 2024 | ||
| Mantle is an engineering and manufacturing company that has developed metal 3D printing technology to produce high-resolution parts that meet the critical needs of applications from automotive and aerospace to consumer product design and prototyping. | $20M / Series C / Jul 10, 2024 | ||
| Cartesian Therapeutics is a fully integrated, clinical-stage biopharmaceutical company developing novel cell and gene immunotherapies to treat cancer and autoimmune diseases. | $130M / Post-IPO Equity / Jul 02, 2024 | ||
| See all 76 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Schooner Capital invest in?
Schooner Capital invests primarily in Software, Biotechnology and Health Care startups, most often at Series A and Funding Round stage. Most of the 76 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Schooner Capital's check size?
Schooner Capital typically joins rounds of $2.3M–$84M at Series A and $1.5M–$21M at Venture - Series Unknown. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Schooner Capital participates in.
How do I contact Schooner Capital?
Public channels for Schooner Capital include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Schooner Capital?
The team at Schooner Capital includes Alexandra Manick (Principal), Jake Fiechter (Analyst) and Jon Corbett (Vice President of Finance), among 10 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
